Study Tool
Apart from the demographic characteristics of patients, our own survey
study consisting of 25 questions was planned. The survey was designed by
the doctor as a Turkish native language. The survey consisting of 25
questions in total was outlined in 3 sections. In the first section,
patients were asked general information about COVID-19. In the second
section, questions were raised about their thoughts on prevention
methods. In the third part, questions were asked about the COVID-19
outbreak and cancer. Except for 2 questions in the survey, the answers
were designed to consist of 3 options. In order to be easy and clear,
the majority of options were created as ”yes, no or not sure”. Knowledge
on the subject of COVID-19 was evaluated by answering 11 multiple-choice
questions followed by the calculation of a total cumulative knowledge
score for every contributor. Questions were given one point for correct
response and zero point for incorrect answers or unsure answers. The
maximum score was 11, and the minimum was 0. Interviews were conducted
in the outpatient room taking into account the rules of pandemic
isolation and social distance with patients applying for routine control
or treatment process. The purpose of the study and absolute
confidentiality of personal information was explained to the patients by
the attending physician. Patients who were over 18 years of age, who had
normal intelligence levels as clinical observation and who did not have
organic brain syndrome, who were not in the terminal period of cancer,
and who agreed to the study were included in the study. Individuals with
brain metastasis or primary brain tumors were not included in the study.